Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Equity Average (2016 - 2025)

Surgery Partners' Equity Average history spans 11 years, with the latest figure at $1.7 billion for Q4 2025.

  • For Q4 2025, Equity Average fell 29.77% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, down 29.77%, while the annual FY2025 figure was $1.8 billion, 27.4% down from the prior year.
  • Equity Average for Q4 2025 was $1.7 billion at Surgery Partners, down from $2.4 billion in the prior quarter.
  • Across five years, Equity Average topped out at $3.2 billion in Q2 2025 and bottomed at $993.7 million in Q1 2021.
  • The 5-year median for Equity Average is $2.5 billion (2024), against an average of $2.4 billion.
  • The largest annual shift saw Equity Average surged 109.26% in 2021 before it fell 29.77% in 2025.
  • A 5-year view of Equity Average shows it stood at $1.8 billion in 2021, then surged by 43.3% to $2.5 billion in 2022, then grew by 19.32% to $3.0 billion in 2023, then dropped by 18.59% to $2.5 billion in 2024, then dropped by 29.77% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Equity Average are $1.7 billion (Q4 2025), $2.4 billion (Q3 2025), and $3.2 billion (Q2 2025).